Medicure http://medicure.mediaroom.com/ Medicure Announces FDA Approval Received for Prexxartan® http://medicure.mediaroom.com/2017-12-19-Medicure-Announces-FDA-Approval-Received-for-Prexxartan-R Tue, 19 Dec 2017 17:30:00 -0500 http://medicure.mediaroom.com/2017-12-19-Medicure-Announces-FDA-Approval-Received-for-Prexxartan-R Medicure Acquires Exclusive License to Sell and Market Branded Cardiovascular Drug in the U.S. http://medicure.mediaroom.com/2017-12-14-Medicure-Acquires-Exclusive-License-to-Sell-and-Market-Branded-Cardiovascular-Drug-in-the-U-S Thu, 14 Dec 2017 10:17:00 -0500 http://medicure.mediaroom.com/2017-12-14-Medicure-Acquires-Exclusive-License-to-Sell-and-Market-Branded-Cardiovascular-Drug-in-the-U-S Medicure Reports Financial Results for Quarter Ended September 30, 2017 http://medicure.mediaroom.com/2017-11-21-Medicure-Reports-Financial-Results-for-Quarter-Ended-September-30-2017 Tue, 21 Nov 2017 17:00:00 -0500 http://medicure.mediaroom.com/2017-11-21-Medicure-Reports-Financial-Results-for-Quarter-Ended-September-30-2017 Medicure Announces Repayment of Outstanding Debt http://medicure.mediaroom.com/2017-11-17-Medicure-Announces-Repayment-of-Outstanding-Debt Fri, 17 Nov 2017 16:00:00 -0500 http://medicure.mediaroom.com/2017-11-17-Medicure-Announces-Repayment-of-Outstanding-Debt Medicure Q3 Results and Conference Call Dates http://medicure.mediaroom.com/2017-11-15-Medicure-Q3-Results-and-Conference-Call-Dates Wed, 15 Nov 2017 18:00:00 -0500 http://medicure.mediaroom.com/2017-11-15-Medicure-Q3-Results-and-Conference-Call-Dates